Intersect ENT, Inc.
XENTDelisted May 13, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001271214
Intersect ENT, Inc. was delisted on May 13, 2022; its insiders filed their last Form 4 on May 16, 2022; 131 institutions reported holding it in 13F filings for Q1 2022, worth $828.8M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Intersect ENT, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Intersect ENT, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mead Dana G Jr. | Director | 0 | May 16, 2022 | 0 |
| Meier Richard A | EVP & Chief Financial Officer | 0 | May 16, 2022 | 0 |
| Broderick Patrick A | EVP, GC & Corporate Secretary | 0 | May 16, 2022 | 0 |
| Gallahue Kieran | Director | 0Indirect | May 16, 2022 | 0 |
| Lucchese Cynthia L | Director | 0 | May 16, 2022 | 0 |
| West Thomas A. | President and CEO | 0 | May 16, 2022 | 0 |
| Sandoval Elisabeth | Director | – | May 16, 2022 | 0 |
| Kline Teresa L. | Director | 0 | May 16, 2022 | 0 |
| Fernandez Reyna M | Chief Human Resource Officer | 0 | May 16, 2022 | 0 |
| Hattangadi Neil A | Director | – | May 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.